Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial. - Yamanaka T; Sohn J; Sudo K; Mukai H; Yamamoto N; Chung CF; Lu YS; Lee KH; Lee SC; Iwasa T; Iwata H; Watanabe K; et al. (Breast cancer (Tokyo, Japan), 2026)